Skip to main content
OpenTrials

Clinical trial condition

Colonic Diseases

Explore clinical trials studying Colonic Diseases. Study availability and eligibility vary by location and protocol.

7,486 public trials 1,473 recruiting studies
Refine in advanced search Browse all conditions

Colonic Diseases trial results

Active, Not Recruiting

A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

NCT06710847

Conditions
Colon Cancer, Colonic Diseases, Colonic Neoplasms, +26 more
Locations
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Detroit, Michigan, United States
  • GSK Investigational Site New York, United States
View all 22 locations
View Trial Details
Active, Not Recruiting

A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer

NCT04854668

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • The People's Hospital of Chizhou Chizhou, Anhui, China
  • Fujian Medical University Union Hospital Fuzhou, Anhui, China
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Anhui Cancer Hospital Hefei, Anhui, China
View all 92 locations
View Trial Details
Active, Not Recruiting

Determination of the Optimal Treatment Target in Ulcerative Colitis

NCT04259138

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +5 more
Locations
  • St. Joseph Mercy Hospital/Huron Gastroenterology Associates Ypsilanti, Michigan, United States
  • Icahn School of Medicine at Mt Sinai Hospital New York, United States
  • New York-Presbyterian/Weill Cornell Medical Center New York, United States
  • Digestive Health Partners - Asheville Gastroenterology Associate Asheville, North Carolina, United States
View all 58 locations
View Trial Details
Active, Not Recruiting

Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer

NCT04137107

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +10 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
View all 793 locations
View Trial Details

Related conditions